NN7999-4031: A Non-Interventional Post-Authorisation Safety Study (PASS) in male haemophilia B patients receiving Nonacog Beta Pegol (N9-GP) prophylaxis treatment First published 27/11/2018 Last updated 02/07/2024 EU PAS number:EUPAS26592 Study Ongoing